Figure 6 | Scientific Reports

Figure 6

From: Clinicopathological Significance of CDKN2A Promoter Hypermethylation Frequency with Pancreatic Cancer

Figure 6

All three included studies estimated the relationship between OS and CDKN2A methylation.

(a).The pooled HR for OS showed that CDKN2A hypermethylation was associated with worse survival in PENs, HR = 4.52, 95% CI = 1.25–16.35, P = 0.02. (b). The pooled HR for OS showed that CDKN2A hypermethylation was associated with worse survival in pancreatic cancer, HR = 4.46, 95% CI = 1.37–14.53, P = 0.01.

Back to article page